Neumora Stock
HealthTechLooking to sell Neumora stock or options?
Neumora is a clinical-stage biotechnology company that is at the forefront of pioneering precision medicines for brain diseases, achieved through the amalgamation of data science and neuroscience. The company provides a precision neuroscience platform that effectively navigates through the complexity of brain disease heterogeneity to accurately match patient populations to targeted therapeutics. This assists doctors in providing more specific treatments for distinct groups of patients, while aiding researchers in creating more effective studies for their evaluation.
Altitude Life Science Ventures, Citadel Enterprise Americas, Surveyor Capital, SoftBank Investment Advisers, Mubadala Capital-Ventures, re.Mind Capital, Vertex Ventures HC, Amgen, Logos Capital, Biomatics Capital, The Invus Group, Alexandria Venture Investments, Polaris Partners, Waycross Ventures, ARCH Venture Partners, Exor, Mercury Fund, F-Prime Capital, Newpath Partners, Abu Dhabi Growth Fund, Catalio Capital Management.